Hong Kong Media Stock News

SEHK:563
SEHK:563Real Estate

Shanghai Industrial Urban Development Group (SEHK:563) Loss Worsens And Reinforces Bearish Earnings Narratives

Shanghai Industrial Urban Development Group (SEHK:563) has reported FY 2025 first half revenue of HK$1,827.8 million, with a basic EPS loss of HK$0.10. This puts the focus firmly on how efficiently that top line is translating into bottom line results. Over the past year of reported periods, revenue has ranged from HK$2,980.8 million in 1H 2024 to HK$9,459.5 million in 2H 2024. Over the same intervals, basic EPS has moved between a loss of HK$0.02 and a loss of HK$0.10, giving investors a...
SEHK:135
SEHK:135Gas Utilities

Kunlun Energy (SEHK:135) Margin Compression Challenges Bullish Narratives After FY 2025 Results

Kunlun Energy FY 2025 earnings snapshot Kunlun Energy (SEHK:135) has reported fresh numbers for FY 2025, with first half revenue of C¥97.5b and basic EPS of C¥0.37. The company’s revenue moved from C¥94.1b and EPS of C¥0.31 in 2H 2024 to C¥97.5b and C¥0.37 in 1H 2025. Trailing twelve month EPS is C¥0.62 on revenue of C¥195.8b, leaving investors weighing a modest earnings profile against margins that remain relatively thin. See our full analysis for Kunlun Energy. With the headline figures...
SEHK:2591
SEHK:2591Biotechs

Guangzhou Innogen Pharmaceutical Group (SEHK:2591) Heavy Losses Challenge High Growth Narratives

Guangzhou Innogen Pharmaceutical Group (SEHK:2591) has reported its FY 2025 first half with revenue of C¥56.4 million, a basic EPS loss of C¥0.29 and net income loss of C¥122.47 million, while trailing twelve month figures show revenue of C¥131.5 million, a basic EPS loss of C¥0.79 and net income loss of C¥341.36 million. The company has seen first half revenue move from C¥0 in FY 2024 to C¥56.4 million in FY 2025 as EPS moved from a basic loss of C¥0.18 to a loss of C¥0.29. This sets up a...
SEHK:2111
SEHK:2111Luxury

Best Pacific International Holdings (SEHK:2111) Margin Drift Challenges Bullish EPS Growth Narrative

Best Pacific International Holdings (SEHK:2111) has posted its FY 2025 first half results with revenue of HK$2,329.8 million and basic EPS of HK$0.25, setting the tone against a backdrop of forecast earnings growth of about 18.6% per year and revenue growth of roughly 8.8% per year. The company has seen revenue move from HK$2,385.4 million in 1H 2024 to HK$2,675.9 million in 2H 2024 and then to HK$2,329.8 million in 1H 2025, while EPS has shifted from HK$0.27 to HK$0.32 and now HK$0.25. This...
SEHK:2269
SEHK:2269Life Sciences

WuXi Biologics (SEHK:2269) Margin Improvement Challenges Bearish Profitability Narratives

WuXi Biologics (Cayman) (SEHK:2269) has reported its FY 2025 numbers with second half revenue of about C¥11.8b and basic EPS of C¥0.64, supported by trailing twelve month revenue of roughly C¥21.8b and EPS of C¥1.22 that sit alongside a 46.3% year over year earnings gain. The company has seen revenue move from around C¥18.7b to C¥21.8b on a trailing basis, while trailing EPS has shifted from C¥0.82 to C¥1.22, setting up a story where rising profit levels are paired with healthier margins that...
SEHK:2097
SEHK:2097Hospitality

Mixue Group (SEHK:2097) Earnings Growth Of 32.7% Tests High P/E Valuation Concerns

MIXUE Group (SEHK:2097) FY 2025 earnings snapshot MIXUE Group (SEHK:2097) has reported FY 2025 results with second half revenue of C¥18.7b and basic EPS of C¥2.82, alongside trailing 12 month revenue of C¥33.6b and EPS of C¥7.83, giving investors a fresh look at how the business is scaling. The company has seen revenue move from C¥10.7b and EPS of C¥5.23 in the first half of 2024 to C¥14.9b and EPS of C¥7.23 in the first half of 2025, with trailing 12 month revenue stepping up from C¥24.8b...
SEHK:636
SEHK:636Logistics

Is KLN Logistics Group (SEHK:636) Now Offering Value After Multi Year Share Price Weakness

This article examines whether KLN Logistics Group at HK$6.65 could be a potential bargain or a value trap, and walks through key signals to help you frame that question clearly. The stock has recently been under pressure, with returns of 1.8% over 7 days, 4.9% over 30 days, 7.9% year to date and 0.8% over the past year, alongside declines of 39.0% and 50.4% across 3 and 5 years respectively. Recent attention around KLN Logistics Group has focused less on short term headlines and more on how...
SEHK:9992
SEHK:9992Specialty Retail

Is Pop Mart International Group (SEHK:9992) Price Justified After Its Strong Multi‑Year Share Surge?

Many investors are considering whether Pop Mart International Group shares still represent good value after a strong run, or whether the price has already moved ahead of the fundamentals. The stock last closed at HK$217.2, with returns of 0.8% over 7 days, an 11.1% decline over 30 days, 12.5% year to date and 71.9% over 1 year, along with a very large 3-year return. Recent attention has focused on how Pop Mart fits into consumer trends in collectibles and branded merchandise, with investors...
SEHK:816
SEHK:816Real Estate

Jinmao Property Services (SEHK:816) Margin Decline Challenges Bullish Earnings Growth Narratives

Jinmao Property Services (SEHK:816) has released its FY 2025 results with first half revenue of C¥1.8b and basic EPS of C¥0.20, setting the tone for how the full year is shaping up. The company has seen revenue move from C¥1.49b in 1H 2024 to C¥1.47b in 2H 2024 and then to C¥1.78b in 1H 2025, while basic EPS has ranged from C¥0.19 in 1H 2024 to C¥0.22 in 2H 2024 and C¥0.20 in 1H 2025. This gives investors a clearer view of how the top line and EPS are tracking across recent periods. With...
SEHK:662
SEHK:662Insurance

Asia Financial Holdings (SEHK:662) Margin Expansion Challenges Low P/E Value Narrative

Asia Financial Holdings (SEHK:662) has just posted its FY 2025 first half numbers, with revenue of HK$1,772.6 million, basic EPS of HK$0.46 and trailing 12 month EPS of HK$1.14 anchoring the latest set of results. The company has seen revenue move from HK$1,915.6 million in 1H FY 2024 to HK$1,848.8 million in 2H FY 2024 and HK$1,772.6 million in 1H FY 2025. Basic EPS tracked from HK$0.39 to HK$0.31 and now HK$0.46, setting the context for the reported 62.7% year over year earnings growth and...
SEHK:683
SEHK:683Real Estate

Kerry Properties (SEHK:683) EPS Rebound To HK$0.42 Tests Bearish Profitability Narratives

Kerry Properties (SEHK:683) has released its FY 2025 figures with first half revenue at HK$8.1b and basic EPS of HK$0.42, setting the tone for how the rest of the year might look. Over the last three reported halves, revenue has moved from HK$5.0b in 1H 2024 to HK$14.5b in 2H 2024 and then to HK$8.1b in 1H 2025. Over the same periods, basic EPS has shifted from HK$0.54 to HK$0.01 and then to HK$0.42, giving investors a clearer view of how the topline and EPS pattern is evolving through the...
SEHK:3918
SEHK:3918Hospitality

NagaCorp (SEHK:3918) Net Margin Surge Tests Single Market Risk Narratives

NagaCorp (SEHK:3918) has put up a solid set of FY 2025 numbers, with first half revenue of US$320.6 million and basic EPS of US$0.0336, set against reported earnings growth of 182.8% year over year and a five year compound growth rate of 45.7% per year. The company has seen revenue move from US$252.9 million in the second half of 2024 to US$320.6 million in the first half of 2025, while basic EPS shifted from US$0.0250 to US$0.0336 over the same periods. Investors will be weighing these...
SEHK:6181
SEHK:6181Luxury

Laopu Gold (SEHK:6181) EPS Surge To C¥13.38 Tests Bullish Growth Narratives

Laopu Gold (SEHK:6181) has released its FY 2025 numbers with first half revenue of C¥12.4b and basic EPS of C¥13.38, set against trailing twelve month revenue of C¥27.3b and EPS of C¥28.35 that reflect earnings growth of 230.5% over the past year and an average of 66.3% per year over five years. Over recent periods the company has seen revenue move from C¥3.5b in 1H 2024 to C¥5.0b in 2H 2024 and then to C¥12.4b in 1H 2025, while basic EPS has shifted from C¥4.11 to C¥5.27 and then to C¥13.38,...
SEHK:81
SEHK:81Real Estate

China Overseas Grand Oceans Group (SEHK:81) Tight 0.8% Margin Reinforces Bearish Profitability Narratives

China Overseas Grand Oceans Group (SEHK:81) has put fresh numbers on the table for FY 2025, with first half revenue at C¥14.5b and basic EPS of C¥0.08. The trailing 12 month view shows revenue of C¥36.9b and EPS of C¥0.09 as the broader backdrop. Over the past three reported halves, revenue has moved from C¥21.9b in 1H 2024 to C¥24.0b in 2H 2024 and then to C¥14.5b in 1H 2025, with basic EPS shifting from C¥0.25 to C¥0.02 and then C¥0.08. This sets up a mixed picture that investors will weigh...
SEHK:2268
SEHK:2268Life Sciences

WuXi XDC Cayman (SEHK:2268) Margin Slip Tests Bullish Growth Narrative After FY 2025 Earnings

WuXi XDC Cayman (SEHK:2268) has posted FY 2025 results that put the focus squarely on scale, with second half revenue of C¥3.2b and basic EPS of C¥0.60, underpinned by trailing twelve month revenue of C¥5.9b and EPS of C¥1.22. The company has seen revenue move from C¥2.4b in the second half of 2024 to C¥3.2b in the second half of 2025, with basic EPS over that period shifting from C¥0.48 to C¥0.60 as investors weigh a trailing net margin of 24.9% against a slightly lower level a year ago. See...
SEHK:386
SEHK:386Oil and Gas

Is It Time To Reassess Sinopec (SEHK:386) After The Recent Share Price Pullback?

Wondering whether China Petroleum & Chemical at HK$4.53 still offers value, or if the easy gains are behind it? This article walks through what the current price really reflects. The stock has seen a 5.0% decline over the last 7 days and a 16.3% decline over the last 30 days, yet it shows returns of 15.5% over 1 year, 23.5% over 3 years and 67.3% over 5 years. Recent market conversations around China Petroleum & Chemical have focused on how its share price performance lines up with broader...
SEHK:6990
SEHK:6990Biotechs

Is It Time To Reassess Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) After Recent Share Price Weakness?

Wondering whether Sichuan Kelun-Biotech Biopharmaceutical is still priced attractively, or if the easy value has already been taken? This breakdown focuses squarely on what you are paying versus what you are getting. The share price recently closed at HK$397.60, after a 4.4% decline over the last week and a 4.6% decline over the past month, while the 1 year return sits at 52.6%. Recent news coverage has focused on Sichuan Kelun-Biotech Biopharmaceutical in the context of investor interest in...